Sign in

You're signed outSign in or to get full access.

JS

Jeff Stent

Senior Equity Analyst at BNP Paribas

Sonning, GB

Jeff Stent is a Senior Equity Analyst at BNP Paribas (Exane), specializing in coverage of listed European consumer sector companies, notably including Reckitt Benckiser Group and Mowi ASA. Over his career, Stent has issued influential ratings and investment recommendations on major firms, with his actionable research and sector insights regularly cited in market intelligence. He has established his profile through roles at Exane BNP Paribas, focusing on large-cap European names, with notable upgrades and downgrades such as his March 2022 coverage action on Reckitt Benckiser. Contactable at BNP Paribas' London office, Stent is recognized as an authoritative voice in European consumer stocks analysis, operating within the regulatory framework of a leading international investment bank.

Jeff Stent's questions to UNILEVER (UL) leadership

Question · H1 2025

Jeff Stent of BNP Paribas asked for further clarification on the strategic rationale for retaining a 20% stake in the demerged ice cream business.

Answer

CEO Fernando Fernandez reiterated that retaining the stake demonstrates confidence in the ice cream business's future success and provides stability during its initial period as an independent company. He confirmed the stake would be sold in an orderly manner within five years to cover separation costs and reduce debt.

Ask follow-up questions

Fintool

Fintool can predict UNILEVER logo UL's earnings beat/miss a week before the call

Question · FY 2024

Jeff Stent from BNP Paribas asked if the business, excluding Ice Cream, is expected to achieve its 4-6% midterm growth target in the current year and requested clarification on the primary listing exchange for the demerged Ice Cream business.

Answer

CEO Hein M. Schumacher clarified that the 4-6% growth target applies post-demerger, once the Growth Action Plan has more fully matured, and reiterated the 3-5% guidance for the total company for 2025. He confirmed that with the Netherlands as the country of incorporation, Euronext Amsterdam will serve as the primary listing for the Ice Cream business, supplemented by listings in London and New York.

Ask follow-up questions

Fintool

Fintool can write a report on UNILEVER logo UL's next earnings in your company's style and formatting

Question · Q4 2024

Jeff Stent asked if the business, excluding Ice Cream, would achieve its 4-6% midterm growth target this year. He also sought clarification on whether the Ice Cream business would have a primary listing exchange among the three announced.

Answer

CEO Hein. M. Schumacher stated that for 2025, the company is sticking to its current group guidance of 3-5% growth and will re-evaluate the 4-6% target after the Ice Cream demerger is complete. He confirmed that as the Netherlands is the country of incorporation for the new entity, Euronext Amsterdam will serve as the primary listing location, with additional listings in London and New York.

Ask follow-up questions

Fintool

Fintool can auto-update your Excel models when UNILEVER logo UL reports

Question · Q2 2024

Jeff Stent asked for Heiko Schipper's initial plans for the Nutrition business and requested more detail on the actions being taken to improve the Ice Cream business in Europe, North America, and China.

Answer

CEO Hein M. Schumacher shared that the Nutrition business is healthy and focused on growing its key brands like Knorr and Hellmann's. CFO Fernando Fernandez detailed that in Ice Cream, operational fixes in service and pricing have improved competitiveness in the U.S. and Europe, while the focus in China is on premiumization and distribution expansion to counter weak market conditions.

Ask follow-up questions

Fintool

Fintool can alert you when UNILEVER logo UL beats or misses